[Updated on Apr. 18] Integration of CiNii Articles into CiNii Research

Nuclear factor-kappa B pathway and response in a phase II trial of bortezomib and docetaxel in patients with recurrent and/or metastatic head and neck squamous cell carcinoma.

Bibliographic Information

Title
Nuclear factor-kappa B pathway and response in a phase II trial of bortezomib and docetaxel in patients with recurrent and/or metastatic head and neck squamous cell carcinoma.
Author
Chung CH, Aulino J, Muldowney NJ, Hatakeyama H, et al

Journal

Citations (0)*help

See more

References(0)*help

See more

Related Articles

See more

Related Data

See more

Related Books

See more

Related Dissertations

See more

Related Projects

See more

Related Products

See more

Details

  • CRID
    1010282257027545094
  • Article Type
    journal article
  • Data Source
    • KAKEN

Report a problem

Back to top